148 related articles for article (PubMed ID: 22184516)
1. High lymphoid enhancer-binding factor-1 expression is associated with disease progression and poor prognosis in chronic lymphocytic leukemia.
Erdfelder F; Hertweck M; Filipovich A; Uhrmacher S; Kreuzer KA
Hematol Rep; 2010 Jan; 2(1):e3. PubMed ID: 22184516
[TBL] [Abstract][Full Text] [Related]
2. LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma.
Menter T; Dirnhofer S; Tzankov A
J Clin Pathol; 2015 Jun; 68(6):473-8. PubMed ID: 25713417
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma.
Amador-Ortiz C; Goolsby CL; Peterson LC; Wolniak KL; McLaughlin JL; Gao J; Chen YH
Am J Clin Pathol; 2015 Feb; 143(2):214-22. PubMed ID: 25596247
[TBL] [Abstract][Full Text] [Related]
4. High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid.
Wu W; Zhu H; Fu Y; Shen W; Miao K; Hong M; Xu W; Fan L; Young KH; Liu P; Li J
Oncotarget; 2016 Apr; 7(16):21631-43. PubMed ID: 26950276
[TBL] [Abstract][Full Text] [Related]
5. Chemokine Receptors CCR1 and CCR2 on Peripheral Blood Mononuclear Cells of Newly Diagnosed Patients with the CD38-Positive Chronic Lymphocytic Leukemia.
Kholodnyuk I; Rivkina A; Hippe L; Svirskis S; Kozireva S; Ventina I; Spaka I; Soloveichika M; Pavlova J; Murovska M; Lejniece S
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708233
[TBL] [Abstract][Full Text] [Related]
6. The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.
Chen L; Li J; Zheng W; Zhang Y; Wu Y; Li L; Qian S; Xu W
Leuk Lymphoma; 2007 Sep; 48(9):1785-92. PubMed ID: 17786715
[TBL] [Abstract][Full Text] [Related]
7. [Expression of CLLU1 in patients with chronic lymphocytic leukemia and its prognostic significance].
Chen LJ; Zheng WJ; Wu YJ; Li L; Qian SX; Xu W; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):737-40. PubMed ID: 18457263
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
Patel N; Durkin L; Bodo J; Hsi ED
Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
[TBL] [Abstract][Full Text] [Related]
9. Quantification of CD38 expression in B-cell chronic lymphocytic leukemia (B-CLL): a comparison between antibody binding capacity (ABC) and relative median fluorescence (RMF).
Dignum HM; Summerfield GP; Proctor SJ; Mainou-Fowler T
Leuk Lymphoma; 2004 Jun; 45(6):1167-73. PubMed ID: 15359996
[TBL] [Abstract][Full Text] [Related]
10. [ZAP-70 expression in 24 patients with B cell chronic lymphocytic leukemia].
Wu YJ; Li JY; Zhu GR; Song JH; Xiao B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):237-40. PubMed ID: 16638188
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Utility of Lymphoid Enhancer Binding Factor 1 Immunohistochemistry in Small B-Cell Lymphomas.
Menter T; Trivedi P; Ahmad R; Flora R; Dirnhofer S; Tzankov A; Naresh KN
Am J Clin Pathol; 2017 Mar; 147(3):292-300. PubMed ID: 28395058
[TBL] [Abstract][Full Text] [Related]
12. [Telomere length and telomerase expression activity in mononuclear cells of patients with chronic lymphocytic leukemia].
Ma L; Wang J; Jiang B; Liu YR; Zhang B; Chang NB; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1409-12. PubMed ID: 20030916
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Significance of Combined Expression of ZAP-70 and CD38 in Chronic Lymphocytic Leukemia.
Assem M; Abdel Hamid T; Kohla S; Arsanyos S
J Egypt Natl Canc Inst; 2009 Dec; 21(4):287-97. PubMed ID: 21415865
[TBL] [Abstract][Full Text] [Related]
14. Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes.
Mayr C; Bund D; Schlee M; Moosmann A; Kofler DM; Hallek M; Wendtner CM
Blood; 2005 Feb; 105(4):1566-73. PubMed ID: 15471955
[TBL] [Abstract][Full Text] [Related]
15. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.
Heintel D; Schwarzinger I; Chizzali-Bonfadin C; Thalhammer R; Schwarzmeier J; Fritzer-Szekeres M; Weltermann A; Simonitsch I; Lechner K; Jaeger U
Leuk Lymphoma; 2001; 42(6):1315-21. PubMed ID: 11911414
[TBL] [Abstract][Full Text] [Related]
16. CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia.
Mainou-Fowler T; Porteous A; Nicolle A; Proctor SJ; Anderson JJ; Summerfield G
Int J Oncol; 2008 Jul; 33(1):169-74. PubMed ID: 18575763
[TBL] [Abstract][Full Text] [Related]
17. Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia.
Stamatopoulos B; Meuleman N; Haibe-Kains B; Duvillier H; Massy M; Martiat P; Bron D; Lagneaux L
Clin Chem; 2007 Oct; 53(10):1757-66. PubMed ID: 17702857
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.
Jia M; Zhao HZ; Shen HP; Cheng YP; Luo ZB; Li SS; Zhang JY; Tang YM
Int J Lab Hematol; 2015 Oct; 37(5):631-40. PubMed ID: 25955539
[TBL] [Abstract][Full Text] [Related]
19. [Mutation and expression of LEF1 in adult acute lymphocytic leukemia and their clinical significance].
Liu J; Guo X; Ge Z; Zhang R; Xu JY; Li M; Wu YJ; Qiao C; Qiu HR; Zhang JF; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1212-6. PubMed ID: 25338559
[TBL] [Abstract][Full Text] [Related]
20. Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia.
Johansson P; Eisele L; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J; Nückel H
Leuk Res; 2010 Jul; 34(7):892-8. PubMed ID: 20353875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
